Aug 8, 2012
Hi Dr Mac,
I hope all is well with you. One q. Are the new drugs for hcv, boceprivir and incelvik(not sure of the spelling) as effective as hoped when used with interferon and ribavirin? You're the best, Dr Mac. A true healer of body, mind and soul.
| Response from Dr. McGovern
Thanks for your question and kind comments!
Boceprevir (Victrelis) and telaprevir (Incivek) are two new protease inhibitors that were approved in the spring of 2011. Both greatly improve treatment cure rates in HCV patients compared to dual therapy alone (eg, Peg Interferon plus ribavirin).
TRiple therapy leads to better cure rates in lots of different patients compared to dual therapy including African Americans, HIV infected patients, patients with cirrhosis...etc...It is a big advance.
However, there are MANY drugs on the way from multiple classes that promise to help improve response rates from about 75% with these regimens to greater than 90% with newer agents. We will know more about the effectiveness and safety of these drugs when we see big treatment trials which are coming soon. And some of these trials will be without interferon...
Exciting days ahead!
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Loose Stool After Insertive Anal Sex With Condom What Are The Chances Of HIV
- Red Eyes After Handjob Worried I Have HIV
- Sinus Infection After Swallowing Cum Worried I Have HIV
- Can Hepatitis B Test Return A False Positive?
- Can You Get Genital Warts If You've Never Had Sex?
- Signs And Symptoms Of Being Sick
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.